Missed pancreatic malignancy: pitfalls and tips for the radiologist.

Congress:

ECR 2020

Poster Number:

C-11645

Type:

Educational Exhibit

Keywords:

Not applicable, Neoplasia, Cancer, Diagnostic procedure, Contrast agent-intravenous, MR, CT, Pancreas, Oncology, Abdomen, Oncologic Imaging

Authors:

R. Taravella¹, F. Vernuccio², R. Cannella², G. Brancatelli², M. Midiri²; ¹Palermo, Italy/IT, ²Palermo/IT

DOI:

10.26044/ecr2020/C-11645

DOI-Link:

https://dx.doi.org/10.26044/ecr2020/C-11645

References

[1]. Vernuccio F, et al. Common and uncommon pitfalls in pancreatic imaging: it is not always cancer. Abdom Radiol (2016) 41:283–294.

[2]. Al-Hawary MM, et al. (2013) Mimics of pancreatic ductal adenocarcinoma. Cancer Imaging 13(3):342–349.

[3]. Kim JK, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26(2):313–322.

[4]. Ichikawa T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221(1):107–116.

[5]. Raimondi S, et al. (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24(3):349–358.

[6]. Siegel RL, et al. Cancer statistics 2015. CA Cancer J Clin 2015; 65(1): 5-29.

[7]. Paulson AS, et al. Therapeutic advances in pancreatic cancer. Gastroenterology 2013; 144(6): 1316-1326.

[8]. Ahn SS, et al. Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol 2009; 19(10): 2448-2455.

[9]. Irie H, et al. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging 1997; 22 (4): 429-433.

[10]. Gangi S, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: Retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 2004; 182(4): 897-903.

[11]. Jang KM, et al. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging. Eur J Radiol 2015; 84 (8): 1473-1479.

[12]. Vernuccio F, et al. Undetected pancreatic carcinoma: Retrospective analysis of missed findings at computed tomography. Hell J Radiol 2017; 2(3): 30-35.

[13]. Eberhardt SC, et al. Oncology imaging in the abdomen and pelvis: Where cancer hides. Abdom Imaging 2013; 38(4): 647-671.

[14]. De Jong K, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol. 2010;8:806–811.

[15]. Laffan TA, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol. 2008;191:802–807.

[16]. Farrell JJ. Pancreatic Cysts and Guidelines. Springer Science+Business Media 2017.

[17]. Oyama H, et al Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Gastroenterology. 2020;158(1):226-237.e5.

[18]. Tanaka M, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17(5):738–753.

[19]. Lee JE, et al. Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. Radiology 2019; 00:1–10.

[20]. Kalb B, et al. (2009) MR imaging of cystic lesions of the pancreas. Radiographics 29(6):1749–1765.